Philip Tom
President & Chief Financial Officer at Avertix Medical
New York, New York
Overview
Work Experience
Executive Vice President & Chief Financial Officer
2023 - Current
Avertix is a cutting-edge medical device company offering the first and only FDA-approved Class III implantable device that can detect silent and atypical symptomatic heart attacks in real-time. With a robust portfolio of U.S. patents pertaining to Acute Coronary Syndrome (ACS) events, Avertix is at the forefront of innovation in cardiovascular care and is committed to improving patient outcomes and saving lives through advanced medical technologies. For more information, visit avertix.com.
Avertix Medical is committed to advancing life-sustaining patient care and the long-term management of Advanced Cardiovascular Disease.
Raised $13,480,307.00.
Principal
2020 - 2023
Serial SPAC sponsor
CFO
2018 - 2020
Hudson MX is a Building technology that empowers buyers,agencies and their partners,Reducing the operational costs inherent in the media.
Raised $73,500,000.00 from Ascential.
Investment Team
2014 - 2018
Buyouts and majority recapitalizations in both high-growth and mature software businesses
Insight Partners is a global software investor that partners with high-growth technology, software, and Internet startup companies.
Investment Banking Associate
2012 - 2014
Credit Suisse Group is a financial services company that advises clients in all aspects of finance.
Education
BA
2008 - 2012